Emergent BioSolutions (EBS) Other Non Operating Income (2011 - 2026)
Emergent BioSolutions (EBS) posted quarterly Other Non Operating Income of $13.9 million for Q1 2026, down 80.06% year-over-year from $69.7 million in Q1 2025, and up 200.72% quarter-over-quarter from -$13.8 million in Q4 2025.
Emergent BioSolutions (EBS) Other Non Operating Income (2011 - 2026) Analysis & Trends
Emergent BioSolutions' Other Non Operating Income history runs 16 years deep, the most recent figure standing at $13.9 million for Q1 2026.
- In Q1 2026, Other Non Operating Income fell 80.06% year-over-year to $13.9 million; the TTM figure through Mar 2026 stood at -$7.3 million (down 108.59% YoY), while the FY2025 annual figure was -$12.2 million, down 202.52% from the prior year.
- Other Non Operating Income for Q1 2026 stood at $13.9 million, up from -$13.8 million in the prior quarter.
- The five-year high for Other Non Operating Income was $69.7 million in Q1 2025, with the low at -$13.8 million in Q4 2025.
- The 5-year median for Other Non Operating Income is -$2.7 million (2024), against an average of $4.2 million.
- The sharpest annual moves came in 2022 and 2025: Other Non Operating Income slumped 458.33% in 2022, then surged 2150.0% in 2025.
- Emergent BioSolutions' Other Non Operating Income stood at $6.7 million in 2022, then climbed by 26.87% to $8.5 million in 2023, then plunged by 145.88% to -$3.9 million in 2024, then slumped by 253.85% to -$13.8 million in 2025, then soared by 200.72% to $13.9 million in 2026.
- Business Quant data shows EBS's Other Non Operating Income at $13.9 million in Q1 2026, -$13.8 million in Q4 2025, and -$3.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.15 Bn | 39.49 Bn | 2.15 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - |
| 10 | Emergent BioSolutions | 251.03 Mn | 110.13 Mn | 137.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -20.50 Mn |
| Mar 31, 2026 | 13.90 Mn |
| Dec 31, 2025 | -13.80 Mn |
| Sep 30, 2025 | -3.70 Mn |
| Jun 30, 2025 | -3.70 Mn |
| Mar 31, 2025 | 69.70 Mn |
| Dec 31, 2024 | -3.90 Mn |
| Sep 30, 2024 | 21.90 Mn |
| Jun 30, 2024 | -2.70 Mn |
| Mar 31, 2024 | -3.40 Mn |
| Dec 31, 2023 | 8.50 Mn |
| Sep 30, 2023 | -3.40 Mn |
| Jun 30, 2023 | 6.40 Mn |
| Mar 31, 2023 | -2.40 Mn |
| Dec 31, 2022 | 6.70 Mn |
| Sep 30, 2022 | -13.40 Mn |
| Jun 30, 2022 | -3.00 Mn |
| Mar 31, 2022 | -2.00 Mn |
| Dec 31, 2021 | -900,000.00 |
| Sep 30, 2021 | -2.40 Mn |